Download Bicalutamide

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Drug – Bicalutamide
Office for Human Research Studies
DANA-FARBER / HARVARD CANCER CENTER
Bicalutamide
FDA Approved
Risks Associated with Bicalutamide
Frequent (Between a 10-50% chance that this will happen)
 Difficulty passing stool
 Feeling tired, tiredness, weakness.
 Hot flashes
 Pain
Occasional (Between a 1-10% chance that this will happen)
 Diarrhea, which is frequent, loose watery stools, which can cause dehydration
and may require hospitalization and treatment with intravenous fluids. Severe
and prolonged diarrhea can be life-threatening.
 Build up of fluid in the body or extremities causing swelling.
 The heart is not able to pump blood properly, which can cause weakness and
tiredness, fluid retention, and fluid build-up in the lungs, which can cause
shortness of breath.
 Blood in the urine
 Increased urination at night
 A low number of white blood cells may increase the risk of infection. It may
become life-threatening. Symptoms of infection may include fever, pain, redness,
and/or difficulty breathing.
 Liver damage which can cause fatigue, and jaundice (yellowing of the skin and
eyes). Although this is usually mild and reversible, this can be serious or life
threatening and may require hospitalization and surgery.
 Feeling sick to the stomach
 Inflammation of the liver caused by a virus
CF Builder Generated Version: 05.12.2016
DFCI IRB Approved Version: 05.20.2016